PEPFAR
PEPFAR Spared the Budget Axe
PEPFAR has been spared from the budget rescission package passed by the U.S. Senate and House of Representatives.
JULY 16, 2025
What Do Funding Cuts Mean For the Future of HIV?
Chris Beyrer, MD, MPH, of Duke talks to IDSE about implications of funding cuts on the future of HIV research, ...
APRIL 1, 2025
‘Act Up. Fight Back.’ Hundreds of Scientists and Clinicians Protest Funding Cuts
Hundreds of researchers, clinicians and scientists joined HIV activists in San Francisco during CROI 2025 to ...
MARCH 11, 2025
PEPFAR Saved an Estimated 25 Million Lives
The U.S.-led global effort to combat the AIDS epidemic has saved the lives of at least 25 million worldwide in the ...
MAY 29, 2023
PEPFAR Saved 25 Million Lives
The U.S.-led global effort to combat the AIDS epidemic has saved the lives of at least 25 million worldwide in the ...
MARCH 15, 2023
Mylan’s HIV Combo Received Tentative Approval Under FDA’s PEPFAR Program
Under PEPFAR, Mylan's HIV combination of dolutegravir, emtricitabine and tenofovir was approved.
FEBRUARY 21, 2018
Mylan’s New TLD HIV Drug Approved Under PEPFAR
TLD, an antiretroviral fixed-dose combination, will be available in developing countries as a first-line ART for ...
AUGUST 8, 2017